149 related articles for article (PubMed ID: 16763612)
1. Pathway-specific apoptotic gene expression profiling in chronic lymphocytic leukemia and follicular lymphoma.
Hui D; Satkunam N; Al Kaptan M; Reiman T; Lai R
Mod Pathol; 2006 Sep; 19(9):1192-202. PubMed ID: 16763612
[TBL] [Abstract][Full Text] [Related]
2. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.
Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA
J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of survivin in bone marrow cells from patients with acute lymphocytic leukemia and chronic lymphocytic leukemia.
Nakagawa Y; Yamaguchi S; Hasegawa M; Nemoto T; Inoue M; Suzuki K; Hirokawa K; Kitagawa M
Leuk Res; 2004 May; 28(5):487-94. PubMed ID: 15068902
[TBL] [Abstract][Full Text] [Related]
4. Similarities of prosurvival signals in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarray.
Zha H; Raffeld M; Charboneau L; Pittaluga S; Kwak LW; Petricoin E; Liotta LA; Jaffe ES
Lab Invest; 2004 Feb; 84(2):235-44. PubMed ID: 14767488
[TBL] [Abstract][Full Text] [Related]
5. Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia cells from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile in leukemic cells.
Maffei R; Fiorcari S; Bulgarelli J; Martinelli S; Castelli I; Deaglio S; Debbia G; Fontana M; Coluccio V; Bonacorsi G; Zucchini P; Narni F; Torelli G; Luppi M; Marasca R
Haematologica; 2012 Jun; 97(6):952-60. PubMed ID: 22207686
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients.
Arvaniti E; Ntoufa S; Papakonstantinou N; Touloumenidou T; Laoutaris N; Anagnostopoulos A; Lamnissou K; Caligaris-Cappio F; Stamatopoulos K; Ghia P; Muzio M; Belessi C
Haematologica; 2011 Nov; 96(11):1644-52. PubMed ID: 21750087
[TBL] [Abstract][Full Text] [Related]
7. Premalignant cell dynamics in indolent B-cell malignancies.
Milpied P; Nadel B; Roulland S
Curr Opin Hematol; 2015 Jul; 22(4):388-96. PubMed ID: 26049761
[TBL] [Abstract][Full Text] [Related]
8. Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with In vitro and In vivo chemoresponses.
Kitada S; Andersen J; Akar S; Zapata JM; Takayama S; Krajewski S; Wang HG; Zhang X; Bullrich F; Croce CM; Rai K; Hines J; Reed JC
Blood; 1998 May; 91(9):3379-89. PubMed ID: 9558396
[TBL] [Abstract][Full Text] [Related]
9. MNDA controls the expression of MCL-1 and BCL-2 in chronic lymphocytic leukemia cells.
Bottardi S; Guieze R; Bourgoin V; Fotouhi-Ardakani N; Dougé A; Darracq A; Lakehal YA; Berger MG; Mollica L; Bay JO; Omichinski JG; Milot E
Exp Hematol; 2020 Aug; 88():68-82.e5. PubMed ID: 32682001
[TBL] [Abstract][Full Text] [Related]
10. High expression of bfl-1 contributes to the apoptosis resistant phenotype in B-cell chronic lymphocytic leukemia.
Morales AA; Olsson A; Celsing F; Osterborg A; Jondal M; Osorio LM
Int J Cancer; 2005 Feb; 113(5):730-7. PubMed ID: 15499630
[TBL] [Abstract][Full Text] [Related]
11. Bcl-2 overexpression leads to increases in suppressor of cytokine signaling-3 expression in B cells and de novo follicular lymphoma.
Vanasse GJ; Winn RK; Rodov S; Zieske AW; Li JT; Tupper JC; Tang J; Raines EW; Peters MA; Yeung KY; Harlan JM
Mol Cancer Res; 2004 Nov; 2(11):620-31. PubMed ID: 15561778
[TBL] [Abstract][Full Text] [Related]
12. Surface expression of Bcl-2 in chronic lymphocytic leukemia and other B-cell leukemias and lymphomas without a breakpoint t(14;18).
McCarthy BA; Boyle E; Wang XP; Guzowski D; Paul S; Catera R; Trott J; Yan XJ; Croce CM; Damle R; Yancopoulos S; Messmer BT; Lesser M; Allen SL; Rai KR; Chiorazzi N
Mol Med; 2008; 14(9-10):618-27. PubMed ID: 18633450
[TBL] [Abstract][Full Text] [Related]
13. Nuclear overexpression of lymphoid-enhancer-binding factor 1 identifies chronic lymphocytic leukemia/small lymphocytic lymphoma in small B-cell lymphomas.
Tandon B; Peterson L; Gao J; Nelson B; Ma S; Rosen S; Chen YH
Mod Pathol; 2011 Nov; 24(11):1433-43. PubMed ID: 21685909
[TBL] [Abstract][Full Text] [Related]
14. Disturbed expression of the anti-apoptosis gene, survivin, and EPR-1 in hematological malignancies.
Shinozawa I; Inokuchi K; Wakabayashi I; Dan K
Leuk Res; 2000 Nov; 24(11):965-70. PubMed ID: 11086180
[TBL] [Abstract][Full Text] [Related]
15. [A study on the expression of myeloid cell leukemia 1 proteins and survivin and their relation with B cell apoptosis in non-Hodgkin's lymphoma].
Zuo XL; Zhou X; Meng J; Zhang KJ; Liu XH; Yang HQ
Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):133-5. PubMed ID: 16624124
[TBL] [Abstract][Full Text] [Related]
16. The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells.
Longo PG; Laurenti L; Gobessi S; Sica S; Leone G; Efremov DG
Blood; 2008 Jan; 111(2):846-55. PubMed ID: 17928528
[TBL] [Abstract][Full Text] [Related]
17. Transformation of small B-cell lymphoma into large cell CD30⁺, CD4⁺, Epstein-Barr virus-negative lymphoma.
Shaver AC; Ma L; Vnencak-Jones C; Schwarting RS; Fasig KJ; Kim AS
Arch Pathol Lab Med; 2014 Aug; 138(8):1101-5. PubMed ID: 25076300
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of docetaxel-induced cytotoxicity and apoptosis by all-trans retinoic acid (ATRA) through downregulation of survivin (BIRC5), MCL-1 and LTbeta-R in hormone- and drug resistant prostate cancer cell line, DU-145.
Kucukzeybek Y; Gul MK; Cengiz E; Erten C; Karaca B; Gorumlu G; Atmaca H; Uzunoglu S; Karabulut B; Sanli UA; Uslu R
J Exp Clin Cancer Res; 2008 Sep; 27(1):37. PubMed ID: 18789152
[TBL] [Abstract][Full Text] [Related]
19. CD44 regulates the apoptotic response and promotes disease development in chronic lymphocytic leukemia.
Fedorchenko O; Stiefelhagen M; Peer-Zada AA; Barthel R; Mayer P; Eckei L; Breuer A; Crispatzu G; Rosen N; Landwehr T; Lilienthal N; Möllmann M; Montesinos-Rongen M; Heukamp L; Dürig J; Hallek M; Fingerle-Rowson G; Herling M
Blood; 2013 May; 121(20):4126-36. PubMed ID: 23547049
[TBL] [Abstract][Full Text] [Related]
20. Follicle center lymphoma is associated with significantly elevated levels of BCL-6 expression among lymphoma subtypes, independent of chromosome 3q27 rearrangements.
Jardin F; Buchonnet G; Parmentier F; Contentin N; Leprêtre S; Lenain P; Picquenot JM; Laberge S; Bertrand P; Stamatoullas A; D'Anjou J; Tilly H; Bastard C
Leukemia; 2002 Nov; 16(11):2318-25. PubMed ID: 12399978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]